Product Program year 2025 Source: CMS Open Payments

Nevro

Device Spinal Cord Stimulator

PDI 00813426020510

Open in the dashboard

General payments

$7,087

28 payments

Research payments

$1,863,426

843 payments

Through program year 2025, $7,087 in general payments and $1,863,426 in research payments were reported against Nevro (Spinal Cord Stimulator).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $228 17
2024 General $2,200 2
2024 Research $16,275 10
2023 General $835 7
2023 Research $1,692,139 778
2022 General $3,825 2
2022 Research $155,012 55

Breakdown

Who paid General payments · program years 2022–2025
  1. Nevro Corp. $6,860 11 payments
  2. Globus Medical, Inc. $228 17 payments
Top recipients General payments · program year 2025
  1. Reza Ehsanian Physical Medicine & Rehabilitation · Albuquerque, NM $48 21% · 1 payment
  2. Arash Farahvar Neurological Surgery · Venice, FL $23 10% · 1 payment
  3. Charles Mouch Interventional Pain Medicine · San Marcos, TX $17 8% · 2 payments
  4. Ciara Rubenstein Nurse Practitioner · New Braunfels, TX $17 8% · 2 payments
  5. Shawn Reddy Pain Medicine · Marble Falls, TX $17 7% · 1 payment

The top 5 of 15 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Physical Medicine & Rehabilitation $48 21% · 1 practitioner
  2. Interventional Pain Medicine Pain Medicine $47 20% · 5 practitioners
  3. Anesthesiology $37 16% · 3 practitioners
  4. Podiatrist, Foot & Ankle Surgery Podiatrist $33 15% · 2 practitioners
  5. Neurological Surgery $23 10% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $124 54% · 10 recipients
  2. New Mexico $48 21% · 1 recipient
  3. Florida $36 16% · 2 recipients
  4. New York $10 4% · 1 recipient
  5. Pennsylvania $10 4% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

28 general · 843 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record